CAS 1785665-61-3

Fórmula: C31H39FN2O8

InChI: InChI=1S/C27H35FN2O4.C4H4O4/c1-19(15-20-9-6-7-11-23(20)28)18-30(14-12-22-10-8-13-29(22)2)27(31)21-16-24(32-3)26(34-5)25(17-21)33-4;5-3(6)1-2-4(7)8/h6-7,9,11,15-17,22H,8,10,12-14,18H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b19-15+;2-1+

Clave InChI: MTPOECCHJLVVGO-FDULSSLPSA-N

SMILES: C/C(=C\C1=CC=CC=C1F)/CN(CCC2CCCN2C)C(=O)C3=CC(=C(C(=C3)OC)OC)OC.C(=C/C(=O)O)\C(=O)O

VUF11207 fumarate

CAS: 1785665-61-3

VUF11207 fumarate is an agonist of CXCR7 and a high-potency ligand of CXCR7 (pKi: 8.1).

Fórmula: C₃₁H₃₉FN₂O₈

Pureza: 97.98%

Forma y color: Solid

Peso molecular: 586.65

Ref: TM-T13324

N-(3-(2-Fluorophenyl)-2-methylallyl)-3,4,5-trimethoxy-N-(2-(1-methylpyrrolidin-2-yl)ethyl)benzamide but-2-enedioate

CAS: 1785665-61-3

Fórmula: C₃₁H₃₉FN₂O₈

Pureza: 95%

Forma y color: Solid

Peso molecular: 586.6484

Ref: IN-DA01ENNO

VUF11207 fumarate

CAS: 1785665-61-3

VUF11207 fumarate

Fórmula: C₃₁H₃₉FN₂O₈

Pureza: ≥95%

Peso molecular: 586.65

Ref: 54-BUP08793

VUF 11207 fumarate

CAS: 1785665-61-3

VUF 11207 fumarate is a small molecule that is shown to be an activator of the S1P1 receptor. It has been shown to reduce infarction size and improve tissue perfusion in mouse hearts following ischaemia-reperfusion injury. VUF 11207 fumarate is also a chemoattractant for neutrophils and monocytes, and can inhibit the production of pro-inflammatory cytokines. This drug has also been shown to have a profile of anti-inflammatory effects in tissues, including the suppression of chemokine production, cytometry, and chemoattractant activity.

Fórmula: C₃₁H₃₉FN₂O₈

Pureza: Min. 95%

Peso molecular: 586.6 g/mol

Ref: 3D-KWC66561